FDA Drug recall D-0721-2016
Paricalcitol Capsules, 4 mcg, 30 capsules per bottle, Rx Only, Mfd by: Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-665-30
- FDA Drug
- Class III
- terminated
- Published 2016-02-24
On 2016-02-24 the FDA classified a Class III recall of Paricalcitol Capsules, 4 mcg, 30 capsules per bottle, Rx Only, Mfd by: Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-665-30 by Dr Reddy S Laboratories, citing failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0721-2016 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2015-11-04 |
| Published | 2016-02-24 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Dr Reddy S Laboratories |
| Distribution | US |
Product
Paricalcitol Capsules, 4 mcg, 30 capsules per bottle, Rx Only, Mfd by: Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-665-30
Reason
Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.
Identifiers
| ndc | 55111-663-30 |
|---|---|
| ndc | 55111-663-01 |
| ndc | 55111-663-05 |
| ndc | 55111-663-79 |
| ndc | 55111-663-81 |
| ndc | 55111-664-30 |
| ndc | 55111-664-01 |
| ndc | 55111-664-05 |
| ndc | 55111-664-79 |
| ndc | 55111-664-81 |
| ndc | 55111-665-30 |
| ndc | 55111-665-01 |
| ndc | 55111-665-05 |
| ndc | 55111-665-79 |
| ndc | 55111-665-81 |
| code_info | Lot #s: C404440, Exp 04/2016; C404946, Exp 05/2016; C505704, Exp 07/2017 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0721-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.